Eli Lilly | LLY - Ebitda





Ebitda تغيير تاريخ
AbbVie USD 3.69B 1.68B 2026-03
Abbott USD 2.43B 844M 2026-03
ALKERMES USD 139.22M 58.96M 2026-06
Amgen USD 3.86B 1.28B 2026-03
AstraZeneca USD 5.16B 510M 2026-06
Baxter International USD 309M 756M 2026-03
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Drreddys Laboratories INR 8.63B 12.96B 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.77B 1.98B 2026-03
J&J USD 8.27B 1.08B 2026-03
Medtronic USD 2.81B 119M 2026-03
Merck USD -1.54B 7.84B 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Novartis USD 5.41B 431M 2026-03
Novo Nordisk DKK 34.72B 2.57B 2026-03
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 6.01B 18M 2026-06
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 90.82M 3.99M 2025-12
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Sanofi EUR 2.72B 2.94B 2026-03
United Therapeutics USD 379.5M 83.4M 2025-12
Zoetis USD 939M 101M 2025-12